 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | QIAGEN |
| Street 1: | 19300 Germantown Rd |
| Street 2: | |
| City: | Germantown |
| Province: | |
| Post Code: | 20874 |
| Country: | United States of America |
| Phone: | (240) 686-7700 |
| Organization Email: | QFTinfo@qiagen.com |
| Web Site: | http://www.qiagen.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Our commitment is to enable you, like more than 500,000 customers around the world, to quickly and reliably reach your goal of useful, actionable insights. To this end, QIAGEN offers you innovative solutions that cover every single step along this journey – not just technologies, but bridges from samples to insights. Our QuantiFERON-TB Gold (QFT) test is the ideal solution for the accurate identification of TB infection that is needed for effective disease prevention. The mission of the QFT team is to help facilitate TB prevention through education, partnerships with Public Health and TB eradication initiatives, and support with contact investigations. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Other (please explain) |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| - Every year we give grants to NTCA, NTCA regional events, and Public Health TB events to help foster TB awareness and eduction - We support TB contact investigations with our TBoss service solution to Public Health - This year we supported the voices of TB initiative to offer TB survivors access to travel and training to become advocates in the fight against the disease - Last year we received the Joe Ware Solutions award from the National TB Controllers Association for our outstanding contribution to TB eradication |
|
Geographical Reach | |
| Which country is your headquarters located in: | Germany |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Australia Brazil Canada China Denmark Finland France Germany India Italy Japan Malaysia Mexico Netherlands Norway Poland Singapore Spain Sweden Switzerland Turkey United States of America |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: The mission of the QFT team is to help facilitate TB prevention through education, partnerships with Public Health and TB eradication initiatives, and support with contact investigations. Laboratory Strengthening: Our QuantiFERON-TB Gold (QFT) test is the ideal solution for the accurate identification of TB infection that is needed for effective disease prevention. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | March 9, 2016 |
| Last updated: | April 11, 2016 |